Fast Track growth for UK/Turkey medical travel agency

 

This recognition, says Longevita, demonstrates the public’s desire for safe, expert, highly qualified cosmetic surgery at competitive prices.

Longevita, specialists in medical travel to Turkey for hair, cosmetic and eye surgery, boasted a three year CAGR of 74.37% in sales, from 10,000 medical procedures on UK patients in that time.

The company is headquartered in London, with offices in Istanbul in Izmir. Patients from the UK, Ireland, USA, Canada, France and Australia consult with the Longevita team pre-procedure and for ongoing aftercare. If appropriate, the patients are referred to qualified surgeons who perform hair transplant, plastic surgery, cosmetic dentistry and eye surgery at internationally accredited private hospitals in Turkey.

Longevita has affiliate dental imaging centres around the UK in cities including London, Manchester, Birmingham, Leeds, Bristol and Nottingham. Patients can get their x-rays taken for free in these centres, for treatment planning before they travel to Turkey. The company also offers a range of non-surgical procedures in central London, including Botox, fillers, non-surgical nose jobs, non-surgical facelifts and PRP injections.

Founder and CEO Kagan Seymenoglu said of the Fast Track recognition; “I would like to thank our patients who made us their top choice for medical travel to Turkey, all our medical and non-medical teams in London, Istanbul and Izmir for their hard work. We have seen consistently increasing demand for Longevita services despite the COVID-19 pandemic where travel restrictions, lockdowns and quarantine rules were widespread across the globe. This is an excellent recognition that UK patients are seeking quality but affordable medical procedures so we are happy to assist them with our #bethebestversionofyourself motto.”

Fast Track has published league tables of the UK’s top-performing private companies with The Sunday Times for the past 24 years. Companies were ranked by the compound annual growth rate in their sales over the last three financial years. They had to be registered in the UK and be independent, unquoted and ultimate holding companies. Annualised sales had to exceed £250,000 in the base year and £5 million in the latest year, and an increase in sales from penultimate to the latest year was required. Firms had to have 10 employees or more, and make an operating profit of at least £500,000 in their latest available accounts. The research was carried out by Fast Track in 2020 between August and November.

Advertisement

ADD A NEWS ITEM

Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.

ADD NEWS

Related News

Ireland/UK cross-border healthcare

02 February, 2021

New temporary scheme for Irish patients

Hair transplant tourism to Turkey

02 February, 2021

How one of Turkey’s leading hair clinics is adapting

Turkey medical travel optimism

02 February, 2021

Can inbound medical travel to Turkey rebound this year?

UK medical travel freeze

02 February, 2021

Three reasons why UK medical travel is on hold

Dubai’s medical travel initiatives

19 January, 2021

Dubai explores new markets in Africa